|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
8135222 |
| 003 |
ICU |
| 005 |
20110615162700.0 |
| 008 |
090709s2010 flua b 001 0 eng |
| 010 |
|
|
|a 2009028151
|
| 020 |
|
|
|a 9781420070996 (hardcover : alk. paper)
|
| 020 |
|
|
|a 1420070991 (hardcover : alk. paper)
|
| 035 |
|
|
|a 8135222
|
| 035 |
|
|
|a 2009028151
|
| 035 |
|
|
|a (OCoLC)166872519
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d BTCTA
|d BAKER
|d YDXCP
|d NLM
|d C#P
|d UKM
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM301.42
|b .M37 2010
|
| 060 |
1 |
0 |
|a QV 744
|b M383q 2010
|
| 082 |
0 |
0 |
|a 615/.19
|2 22
|
| 100 |
1 |
|
|a Martin, Yvonne Connolly,
|d 1936-
|0 http://id.loc.gov/authorities/names/n77015352
|1 http://viaf.org/viaf/3723922
|
| 245 |
1 |
0 |
|a Quantitative drug design :
|b a critical introduction /
|c Yvonne Connolly Martin.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Boca Raton :
|b CRC Press/Taylor & Francis,
|c c2010.
|
| 300 |
|
|
|a xv, 282 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Overview of quantitative drug design -- Noncovalent interactions in biological systems -- Preparation of 3D structures of molecules for 3D QSAR -- Calculating physical properties of molecules -- Biological data -- Form of equations that relate potency and physical properties -- Statistical basis of regression and partial least-squares analysis -- Strategy for the statistical evaluation of a data set of related molecules -- Detailed examples of QSAR calculations on erythromycin esters -- Case studies -- Methods to approach other structure-activity problems.
|
| 650 |
|
0 |
|a Drugs
|x Structure-activity relationships.
|0 http://id.loc.gov/authorities/subjects/sh85039752
|
| 650 |
|
0 |
|a QSAR (Biochemistry)
|0 http://id.loc.gov/authorities/subjects/sh91000992
|
| 650 |
|
0 |
|a Drugs
|x Design.
|0 http://id.loc.gov/authorities/subjects/sh88001157
|
| 650 |
1 |
2 |
|a Drug Design.
|
| 650 |
2 |
2 |
|a Biopharmaceutics.
|
| 650 |
2 |
2 |
|a Models, Theoretical.
|
| 650 |
2 |
2 |
|a Quantitative Structure-Activity Relationship.
|
| 650 |
|
7 |
|a Drugs
|x Design.
|2 fast
|0 http://id.worldcat.org/fast/fst00898790
|
| 650 |
|
7 |
|a Drugs
|x Structure-activity relationships.
|2 fast
|0 http://id.worldcat.org/fast/fst00898929
|
| 650 |
|
7 |
|a QSAR (Biochemistry)
|2 fast
|0 http://id.worldcat.org/fast/fst01084801
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 79903a98-e86d-56a5-8382-ad3a86278d01
|s cc4cb514-ce9a-5f65-be60-e6b764237bef
|
| 928 |
|
|
|t Library of Congress classification
|a RM301.42 .M37 2010
|l JCL
|c JCL-Sci
|i 1223766
|
| 927 |
|
|
|t Library of Congress classification
|a RM301.42 .M37 2010
|l JCL
|c JCL-Sci
|e CRERAR
|b 099645130
|i 8813104
|
